blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1513928

EP1513928 - A BANK OF STEM CELLS FOR PRODUCING CELLS FOR TRANSPLANTATION HAVING HLA ANTIGENS MATCHING THOSE OF TRANSPLANT RECIPIENTS, AND METHODS FOR MAKING AND USING SUCH A STEM CELL BANK [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.07.2020
Database last updated on 19.07.2024
FormerThe patent has been granted
Status updated on  19.07.2019
FormerGrant of patent is intended
Status updated on  24.03.2019
FormerExamination is in progress
Status updated on  06.12.2016
Most recent event   Tooltip24.06.2022Lapse of the patent in a contracting state
New state(s): CY, HU
published on 27.07.2022  [2022/30]
Applicant(s)For all designated states
Advanced Cell Technology, Inc.
One Innovation Drive
Worcester, MA 01605 / US
[2005/11]
Inventor(s)01 / WEST, Michael, D.
One Innovation Drive
Worcester, MA 01605 / US
 [2005/11]
Representative(s)Daniels, Jeffrey Nicholas, et al
Page White & Farrer Limited
Bedford House
21A John Street
London WC1N 2BF / GB
[N/P]
Former [2019/34]Daniels, Jeffrey Nicholas, et al
Page White & Farrer
Bedford House
John Street
London WC1N 2BF / GB
Former [2005/11]Daniels, Jeffrey Nicholas, et al
Page White & Farrer 54 Doughty Street
London WC1N 2LS / GB
Application number, filing date03736723.227.05.2003
[2005/11]
WO2003US16626
Priority number, dateUS20020382616P24.05.2002         Original published format: US 382616 P
US20030448585P21.02.2003         Original published format: US 448585 P
[2005/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03100018
Date:04.12.2003
Language:EN
[2003/49]
Type: A2 Application without search report 
No.:EP1513928
Date:16.03.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 04.12.2003 takes the place of the publication of the European patent application.
[2005/11]
Type: B1 Patent specification 
No.:EP1513928
Date:21.08.2019
Language:EN
[2019/34]
Search report(s)International search report - published on:US14.10.2004
(Supplementary) European search report - dispatched on:EP04.06.2007
ClassificationIPC:C12N15/873, A61K35/12, C12N5/0735
[2019/12]
CPC:
C12N15/873 (EP); C12N5/0606 (EP); A61K35/12 (EP);
C12N2510/00 (EP); C12N2517/10 (EP)
Former IPC [2005/11]C12N5/00, C12N5/02, C12N5/06, C12N5/10, C12N5/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2019/34]
Former [2005/11]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:STAMMZELLBANK ZUR PRODUKTION VON DEN HLA-ANTIGENEN VON TRANSPLANTATIONSEMPFÄNGERN ENTSPRECHENDE HLA-ANTIGENE AUFWEISENDEN ZELLEN FÜR DIE TRANSPLANTATION UND VERFAHREN ZUR HERSTELLUNG UND ZUR VERWENDUNG EINER SOLCHEN ST AMMZELLBANK[2005/11]
English:A BANK OF STEM CELLS FOR PRODUCING CELLS FOR TRANSPLANTATION HAVING HLA ANTIGENS MATCHING THOSE OF TRANSPLANT RECIPIENTS, AND METHODS FOR MAKING AND USING SUCH A STEM CELL BANK[2005/11]
French:BANQUE DE CELLULES SOUCHES DESTINEES A LA PRODUCTION DE CELLULES POUR TRANSPLANTATION POSSEDANT DES ANTIGENES HLA CORRESPONDANT A CEUX DES RECEVEURS DE TRANSPLANT, ET PROCEDES DE CONSTITUTION ET D'UTILISATION D'UNE TELLE BANQUE DE CELLULES SOUCHES[2005/11]
Entry into regional phase21.12.2004National basic fee paid 
21.12.2004Search fee paid 
21.12.2004Designation fee(s) paid 
21.12.2004Examination fee paid 
Examination procedure19.12.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
21.12.2004Examination requested  [2005/11]
28.08.2009Despatch of a communication from the examining division (Time limit: M08)
25.08.2010Reply to a communication from the examining division
22.09.2011Despatch of a communication from the examining division (Time limit: M06)
02.04.2012Reply to a communication from the examining division
05.10.2012Despatch of a communication from the examining division (Time limit: M06)
12.04.2013Reply to a communication from the examining division
30.07.2015Despatch of a communication from the examining division (Time limit: M06)
04.03.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
13.05.2016Reply to a communication from the examining division
25.11.2016Despatch of a communication from the examining division (Time limit: M06)
05.06.2017Reply to a communication from the examining division
11.12.2017Despatch of a communication from the examining division (Time limit: M06)
19.06.2018Reply to a communication from the examining division
25.03.2019Communication of intention to grant the patent
12.07.2019Fee for grant paid
12.07.2019Fee for publishing/printing paid
12.07.2019Receipt of the translation of the claim(s)
Divisional application(s)EP11179101.8   Application refused  : 11.02.2012
EP13186524.8  / EP2679671
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.08.2009
Opposition(s)03.06.2020No opposition filed within time limit [2020/32]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
13.05.2016Request for further processing filed
13.05.2016Full payment received (date of receipt of payment)
Request granted
13.05.2016Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
25.08.2010Request for further processing filed
25.08.2010Full payment received (date of receipt of payment)
Request granted
02.09.2010Decision despatched
Fees paidRenewal fee
12.05.2005Renewal fee patent year 03
23.03.2006Renewal fee patent year 04
26.09.2007Renewal fee patent year 05
24.11.2008Renewal fee patent year 06
25.08.2009Renewal fee patent year 07
25.05.2010Renewal fee patent year 08
25.05.2011Renewal fee patent year 09
25.05.2012Renewal fee patent year 10
28.05.2013Renewal fee patent year 11
27.05.2014Renewal fee patent year 12
15.06.2015Renewal fee patent year 13
27.05.2016Renewal fee patent year 14
31.05.2017Renewal fee patent year 15
01.06.2018Renewal fee patent year 16
28.05.2019Renewal fee patent year 17
Penalty fee
Additional fee for renewal fee
31.05.200705   M06   Fee paid on   26.09.2007
31.05.200806   M06   Fee paid on   24.11.2008
31.05.200907   M06   Fee paid on   25.08.2009
31.05.201513   M06   Fee paid on   15.06.2015
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.05.2003
AT21.08.2019
CY21.08.2019
CZ21.08.2019
DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
IT21.08.2019
MC21.08.2019
NL21.08.2019
RO21.08.2019
SE21.08.2019
SI21.08.2019
SK21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
IE27.05.2020
LU27.05.2020
BE31.05.2020
CH31.05.2020
FR31.05.2020
LI31.05.2020
[2022/27]
Former [2021/23]AT21.08.2019
CZ21.08.2019
DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
IT21.08.2019
MC21.08.2019
NL21.08.2019
RO21.08.2019
SE21.08.2019
SI21.08.2019
SK21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
IE27.05.2020
LU27.05.2020
BE31.05.2020
CH31.05.2020
FR31.05.2020
LI31.05.2020
Former [2021/20]AT21.08.2019
CZ21.08.2019
DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
IT21.08.2019
MC21.08.2019
NL21.08.2019
RO21.08.2019
SE21.08.2019
SI21.08.2019
SK21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
IE27.05.2020
LU27.05.2020
CH31.05.2020
LI31.05.2020
Former [2021/15]AT21.08.2019
CZ21.08.2019
DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
IT21.08.2019
MC21.08.2019
NL21.08.2019
RO21.08.2019
SE21.08.2019
SI21.08.2019
SK21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
LU27.05.2020
CH31.05.2020
LI31.05.2020
Former [2021/12]AT21.08.2019
CZ21.08.2019
DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
IT21.08.2019
MC21.08.2019
NL21.08.2019
RO21.08.2019
SE21.08.2019
SI21.08.2019
SK21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
CH31.05.2020
LI31.05.2020
Former [2021/08]AT21.08.2019
CZ21.08.2019
DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
IT21.08.2019
NL21.08.2019
RO21.08.2019
SE21.08.2019
SI21.08.2019
SK21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
CH31.05.2020
LI31.05.2020
Former [2020/37]AT21.08.2019
CZ21.08.2019
DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
IT21.08.2019
NL21.08.2019
RO21.08.2019
SE21.08.2019
SI21.08.2019
SK21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
Former [2020/26]AT21.08.2019
CZ21.08.2019
DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
IT21.08.2019
NL21.08.2019
RO21.08.2019
SE21.08.2019
SK21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
Former [2020/23]AT21.08.2019
DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
IT21.08.2019
NL21.08.2019
RO21.08.2019
SE21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
Former [2020/22]DK21.08.2019
EE21.08.2019
ES21.08.2019
FI21.08.2019
NL21.08.2019
SE21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
Former [2020/17]ES21.08.2019
FI21.08.2019
NL21.08.2019
SE21.08.2019
TR21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
Former [2020/12]ES21.08.2019
FI21.08.2019
NL21.08.2019
SE21.08.2019
BG21.11.2019
GR22.11.2019
PT23.12.2019
Former [2020/10]FI21.08.2019
NL21.08.2019
SE21.08.2019
BG21.11.2019
PT23.12.2019
Former [2020/09]FI21.08.2019
NL21.08.2019
Documents cited:Search[PX]US2002155601  (YAN WEN LIANG [US], et al) [PX] 1-133 * the whole document *;
 [PX]WO02102997  (STEMRON INC [US], et al) [PX] 1-133 * the whole document *;
 [T]  - LANZA R P ET AL, "Generation of histocompatible tissues using nuclear transplantation", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (200207), vol. 20, ISSN 1087-0156, pages 689 - 696, XP002955120 [T] * the whole document *

DOI:   http://dx.doi.org/10.1038/nbt703
 [T]  - FADEN RUTH R ET AL, "PUBLIC STEM CELL BANKS: CONSIDERATIONS OF JUSTICE IN STEM CELL RESEARCH AND THERAPY", HASTINGS CENTER REPORT, INSTITUTE OF SOCIETY, ETHICS AND THE LIFE SCIENCES, HASTINGS-O, US, (200311), vol. 33, no. 6, ISSN 0093-0334, pages 13 - 27, XP009077152

DOI:   http://dx.doi.org/10.2307/3527822
 [T]  - TAYLOR ET AL, "Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching", LANCET THE, LANCET LIMITED. LONDON, GB, (20051210), vol. 366, no. 9502, ISSN 0140-6736, pages 2019 - 2025, XP005204962 [T] * the whole document *

DOI:   http://dx.doi.org/10.1016/S0140-6736(05)67813-0
International search[Y]US5192553  (BOYSE EDWARD A [US], et al);
 [Y]US5004681  (BOYSE EDWARD A [US], et al);
 [Y]US5993387  (MOORE THOMAS ELDON [US], et al)
 [Y]  - BRADLEY J., "Stem cell medicine encounters the immune system", NATURE REVIEWS - IMMUNOLOGY, (200211), vol. 2, no. 11, pages 859 - 871, XP002981993

DOI:   http://dx.doi.org/10.1038/nri934
 [Y]  - WOLF S.A., "Storing lifeblood. Cord blood stem cell banking", AM. J. OF NURSING, (199908), vol. 99, no. 8, pages 60 - 63, XP002981994 [Y] * page 66 - page 67 *
 [Y]  - VOGEL G., "BRITISH SCIENCE: Pioneering Stem Cell Bank Will Soon Be Open for Deposits", SCIENCE, (20020913), vol. 297, no. 5588, page 1784, XP002981915

DOI:   http://dx.doi.org/10.1126/science.297.5588.1784a
 [Y]  - ADAMSON J.W., "Cord blood stem cell banking and transplantation", STEM CELLS, (1997), vol. 15, no. SUPPL. 1, pages 57 - 61, XP002982306
 [Y]  - HARRIS D.T., "Experience in autologous and allogeneic cord blood banking", J. OF HEMATOTHERAPY, (199604), vol. 5, no. 2, pages 123 - 128, XP001018554
 [Y]  - KOEGLER G. ET AL, "HLA typing strategies of cord blood (CB) for unrelated stem cell banking within eurocord", HUMAN IMMUNOLOGY, (1996), vol. 47, no. 1-2, ABSTRACT #P474, page 87, XP002981916
ExaminationWO0130978
 WO03046141
    - CIBELLI JOSE B ET AL, "Parthenogenetic Stem Cells in Nonhuman Primates", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, (20020201), vol. 295, no. 5556, doi:10.1126/SCIENCE.1065637, ISSN 0036-8075, page 819, XP008091029

DOI:   http://dx.doi.org/10.1126/science.1065637
    - KIM KITAI ET AL, "Histocompatible embryonic stem cells by parthenogenesis", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, (20070126), vol. 315, no. 5811, doi:10.1126/SCIENCE.1133542, ISSN 0036-8075, pages 482 - 486, XP002467552

DOI:   http://dx.doi.org/10.1126/science.1133542
    - CIBELLI JOSE B ET AL, "Embryonic stem cells from parthenotes", METHODS IN ENZYMOLOGY, ACADEMIC PRESS, US, (20060101), vol. 418, doi:10.1016/S0076-6879(06)18008-8, ISSN 0076-6879, pages 117 - 135, XP009095437

DOI:   http://dx.doi.org/10.1016/S0076-6879(06)18008-8
    - JOSE B CIBELLI ET AL, "Somatic Cell Nuclear Transfer in Humans: Pronuclear and Early Embryonic Development", E-BIOMED, MARY-ANN LIEBERT, LARCHMONT, NY, US, (20011126), vol. 2, no. 5, doi:10.1089/152489001753262168, ISSN 1524-8909, pages 25 - 31, XP002635246

DOI:   http://dx.doi.org/10.1089/152489001753262168
    - MITALIPOV S M ET AL, "PARTHENOGENETIC ACTIVATION OF RHESUS MONKEY OOCYTES AND RECONSTRUCTED EMBRYOS", BIOLOGY OF REPRODUCTION, NEW YORK, NY [U.A.] : ACADEM. PRESS, US, (20010701), vol. 65, no. 1, doi:10.1095/BIOLREPROD65.1.253, ISSN 0006-3363, pages 253 - 259, XP001117868

DOI:   http://dx.doi.org/10.1095/biolreprod65.1.253
    - LIN H ET AL, "MULTILINEAGE POTENTIAL OF HOMOZYGOUS STEM CELLS DERIVED FROM METAPHASE II OOCYTES", STEM CELLS, ALPHAMED PRESS, DAYTON, OH, US, (20030101), vol. 21, no. 2, doi:10.1634/STEMCELLS.21-2-152, ISSN 1066-5099, pages 152 - 161, XP001157416

DOI:   http://dx.doi.org/10.1634/stemcells.21-2-152
by applicantWO02102997
 US2002155601
 WO0130978
 WO03046141
 US6235970
 US5633067
 US5612205
 WO9322432
 US5631153
 US5464764
 WO03061591
 US6200806
 US6280718
 US5851832
    - CIBELLI et al., "discloses parthenogenetic stem cells in nonhuman primates", Science, (20020000), vol. 295, no. 5556, doi:doi:10.1126/science.1065637, page 819, XP008091029

DOI:   http://dx.doi.org/10.1126/science.1065637
    - CIBELLI et al., "discloses somatic cell nuclear transfer in humans: pronuclear and early embryonic development", E-Biomed, (20010000), vol. 2, no. 5, doi:doi:10.1089/152489001753262168, pages 25 - 31, XP002635246

DOI:   http://dx.doi.org/10.1089/152489001753262168
    - LIN et al., "discloses multilineage potential of homozygous stem cells derived from metaphase II oocytes", Stem Cells, (20030000), vol. 21, no. 2, pages 152 - 161
    - MARTIN, Proc. Natl. Acad. Sci. USA, (19810000), vol. 78, pages 7634 - 7638
    - EVANS et al., Nature, (19810000), vol. 292, pages 154 - 156
    - Proc. Natl. Acad. Sci. USA, (19950000), vol. 92, pages 7844 - 7848
    - MITALIPOV et al., Biology of Reproduction, (20010000), vol. 65, pages 253 - 259
    - CIBELLI et al., Science, (20020000), vol. 295, page 81
    - Nature Biotechnology, (20030300), vol. 21
    - THOMSON et al., "also describes methods by which ES cell lines can be derived from primate/human blastocysts", Science, (19880000), vol. 282, pages 1145 - 1147
    - Proc. Natl. Acad. Sci., USA, (19950000), vol. 92, pages 7544 - 7848
    - XU et al., Nature Biotechnology, (20010000), vol. 19, pages 971 - 4
    - PAQUIN et al., Proc. Nat. Acad. Sci, (20020000), vol. 99, pages 9550 - 9555
    - WEISS et al., Hematol. Oncol. Clin. N. Amer, (19970000), vol. 11, no. 6, pages 1185 - 98
    - ASSADY et al., Diabetes, (20010000), vol. 50, no. 8, pages 1691 - 1697
    - REUBINOFF et al., Nature Biotechnology, (20010000), vol. 19, pages 1134 - 1140
    - LIN et al., Stem Cells, (20030000), vol. 21, pages 152 - 161
 US20020227282
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.